Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $436 Million. The most recent transaction as insider was on Jul 20, 2022, when has been sold 40,000 shares (Common Stock) at a price of $167.51 per share, resulting in proceeds of $6,700,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M

0.49% 3M change

1.39% 12M change

Total Value Held $436 Million

Stephane Bancel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 20 2022	SELL Open market or private sale	$6,700,400 $167.51 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jul 20 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jul 14 2022	SELL Open market or private sale	$6,430,800 $160.77 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jul 14 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jul 13 2022	SELL Open market or private sale	$6,942,800 $173.57 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jul 13 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jul 07 2022	SELL Open market or private sale	$6,837,200 $170.93 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jul 07 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jul 06 2022	SELL Open market or private sale	$6,270,000 $156.75 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jul 06 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 30 2022	SELL Open market or private sale	$5,662,800 $141.57 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 30 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 29 2022	SELL Open market or private sale	$5,702,000 $142.55 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 29 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 23 2022	SELL Open market or private sale	$5,616,400 $140.41 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 23 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 22 2022	SELL Open market or private sale	$5,473,600 $136.84 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 22 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 16 2022	SELL Open market or private sale	$4,796,000 $119.9 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 16 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 15 2022	SELL Open market or private sale	$5,111,200 $127.78 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 15 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 09 2022	SELL Open market or private sale	$5,527,200 $138.18 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock
Jun 09 2022	BUY Exercise of conversion of derivative security	$39,600 $0.99 p/Share	40,000 Added 0.73%	5,451,946 Common Stock
Jun 08 2022	SELL Open market or private sale	$6,002,800 $150.07 p/Share	40,000 Reduced 0.73%	5,411,946 Common Stock

Stephane Bancel

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account